If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.
Looks as though Jo Holland has now joined up with old pal Topalczay at Conduit.
https://www.contractpharma.com/contents/view_breaking-news/2024-03-20/conduit-pharmaceuticals-names-dr-joanne-holland-as-chief-scientific-officer/
" Holland earned a PhD in chemistry from the University of Leeds, UK, which was sponsored by Pfizer, Inc., before starting her career at companies including Millennium Pharmaceuticals and Stylacats Limited."
"I do notice however a nice rise this morning, someone is interested in buying into NFX :)"
Are you sure you're looking at NFX?
Unless I'm missing something the bid is 0.18p and the ask is 0.22p - down -2.7% with a total of 112,466 shares traded (about £225)
Back on 29th Feb, OlderButWiser kindly shared a rough transcript of the communication as presented to the Telegram group in which the following points were highlighted:
"• EU patent for 002 is in process of finalisation and will be announced imminently.
• Orphan drug status application submission.
• 004 patents progress and update
• The NEW plan mentioned by Dan, whatever that is, to promote company based upon BD progress and the massive potential (his words) they see.
• The company will update with company presentation soon."
Has ANY of this actually come to pass?
If the EU patent was supposed to be in the process of finalisation, why has nothing been announced in the nearly 2 months since? They could have been over half way through the orphan status process in that time.
Why does the company have nothing to say?
Transhaven, did you get a response to your email?
"No Chab there is no obligation on them to inform shareholders every time they file for a patent, orphan status or a grant."
By the same rule Jiving, If that really is a Nuformix representative then why do they feel obliged to share the company's intentions via a limited confab on Telegram?
Pre-AGM all rumour pointed towards orphan status being the key to any deal. So either that was all BS and they haven't submitted it or they don't want to announce that they have. I don't know the answer to that.
What is remarkably strange though is that there is a deafening silence from a number of individuals who would normally be very quick to pour cold water on anyone suggesting that things might not be moving along. Again, I have no idea why. Hopefully they are all in good health. It just seems unusually strange that they don't have anything at all to say.
I thought Gooding was brought in as a Business Development Consultant back in Mar 2022 (see RNS dated 28 Mar 2022).
Was that not when they decided that things were at a point where it was feasible to start approaching potential partners?